The Josephine Norcia-Riley Memorial Research Grant

Josephine Norcia-Riley was born into a life that would ultimately bring laughter, happiness, and inspiration to everyone who had the fortune of knowing her.

Learn More

Angiosarcoma Awareness Inc.

When I was diagnosed with angiosarcoma, there was almost no information available. I started Angiosarcoma Awareness Inc. in order to generate awareness for this rare cancer as well as to raise funds for research. We are an IRS recognized 501 (c) 3 charity with the mission of finding answers through funding research. -Lauren Ryan

Learn About Us

What is Angiosarcoma?

Microscopic comparison of normal breast tissue with primary angiosarcoma of the breast. Both images are taken at the same magnification – one shows normal breast tissue, the other shows the tumor nearby which is infiltrating through all the breast tissue and trapping the normal breast epithelial structures. Pictures courtesy of Christopher D.M. Fletcher, MD (Chief of Onco-Pathology, Dana-Farber Cancer Institute)

Learn More

Join Our Support Group!

Join our support group on Facebook and connect with others who can truly empathize.  It’s amazing what an incredible ride life gives us, and what is more amazing is how we get through it. Our fate brought us together and we will be sure to let the world know that angiosarcoma cancer is a REALITY. Our voices will be heard and we will SAVE LIVES! WE WILL PREVAIL!

View Group

Recent News RSS

4th Annual Raft 4 Life

July 31st, 2014 - Raft 4 Life as an amazing opportunity to raise funds for research through collaboration with Angiosarcoma Awareness, Inc., all while enjoying life...

Lauren Skop Ryan – We Love You

June 20th, 2014 - The below post was written by Jim Chapdelaine, featured in this photo as well. The words could not be more perfect to...

Our Mission

Angiosarcoma is one of the most aggressive cancers and has a dismal prognosis with a 5 year overall survival rate of 30%. We are in a race against time to find a cure, not only for ourselves, but for all victims of this insidious disease. Because this is such a rare cancer, accounting for only 0.1% of adult malignancies, it is poorly understood. We recognize the fact that unless we create a patient driven initiative to fund angiosarcoma specific research, our rare cancer will never be the focus of large scale scientific endeavors that might shed light on the disease progression. We will identify laboratories that are currently conducting research on angiosarcoma and raise funds to support and augment their work. Our hope is to fund research that will reveal the molecular underpinnings of the disease which might help tailor individual therapies.

Medical Leaders Are Saying…

“Angiosarcoma Awareness has brought much needed attention to this rare disease. As a result of this groups efforts, there is now a large scale scientific endeavor aimed specifically at understanding what drives angiosarcoma. This is already being translated into new clinical trials for patients with this disease”

Gary K. Schwartz, MD, Chief, Melanoma and Sarcoma Memorial Sloan-Kettering Cancer Center

“Angiosarcoma awareness has been supporting our research efforts for the last two years, allowing us to make significant strides toward better understanding of the pathogenesis of angiosarcoma (AS).”

Cristina R. Antonescu, MD, Sarcoma disease management team, Memorial Sloan-Kettering Cancer Center

For more information on our research please,
Visit our Angiosarcoma Research Page